Zhang Hongling, Xu Youdong, Huang Xin, Yang Shunyin, Li Ruiting, Wu Yongran, Zou Xiaojing, Yu Yuan, Shang You
Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China.
Department of Intensive Care Unit, Affiliated Lu'an Hospital, Anhui Medical University, Lu'an, Anhui, 237000, China.
J Intensive Med. 2023 Sep 5;4(1):62-72. doi: 10.1016/j.jointm.2023.07.001. eCollection 2024 Jan.
Sepsis and septic shock remain the leading causes of death in intensive care units. Some patients with sepsis fail to respond to routine treatment and rapidly progress to refractory respiratory and circulatory failure, necessitating extracorporeal membrane oxygenation (ECMO). However, the role of ECMO in adult patients with sepsis has not been fully established. According to existing studies, ECMO may be a viable salvage therapy in carefully selected adult patients with sepsis. The choice of venovenous, venoarterial, or hybrid ECMO modes is primarily determined by the patient's oxygenation and hemodynamics (distributive shock with preserved cardiac output, septic cardiomyopathy (left, right, or biventricular heart failure), or right ventricular failure caused by acute respiratory distress syndrome). Veno-venous ECMO can be used in patients with sepsis and severe acute respiratory distress syndrome when conventional mechanical ventilation fails, and early application of veno-arterial ECMO in patients with sepsis-induced refractory cardiogenic shock may be critical in improving their chances of survival. When ECMO is indicated, the choice of an appropriate mode and determination of the optimal timing of initiation and weaning are critical, particularly in an experienced ECMO center. Furthermore, some special issues, such as ECMO flow, anticoagulation, and antibiotic therapy, should be noted during the management of ECMO support.
脓毒症和脓毒性休克仍然是重症监护病房患者死亡的主要原因。一些脓毒症患者对常规治疗无反应,并迅速进展为难治性呼吸和循环衰竭,需要进行体外膜肺氧合(ECMO)治疗。然而,ECMO在成年脓毒症患者中的作用尚未完全明确。根据现有研究,ECMO对于经过精心挑选的成年脓毒症患者可能是一种可行的挽救治疗方法。静脉-静脉、静脉-动脉或混合ECMO模式的选择主要取决于患者的氧合和血流动力学情况(心输出量保留的分布性休克、脓毒性心肌病(左、右或双心室心力衰竭)或由急性呼吸窘迫综合征引起的右心室衰竭)。当常规机械通气失败时,静脉-静脉ECMO可用于脓毒症合并严重急性呼吸窘迫综合征的患者,而对于脓毒症所致难治性心源性休克患者,早期应用静脉-动脉ECMO可能对提高其生存几率至关重要。当需要使用ECMO时,选择合适的模式以及确定开始和撤机的最佳时机至关重要,尤其是在经验丰富的ECMO中心。此外,在ECMO支持治疗过程中,还应注意一些特殊问题,如ECMO流量、抗凝和抗生素治疗等。